CAS: 1481677-78-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | UNC-0642 REF: IN-DA00AQBWCAS: 1481677-78-4 | 98% | To inquire | Tue 07 Jan 25 |
 | UNC0642 REF: TM-T4166CAS: 1481677-78-4 | 98.75% - 99.5% | 40.00 €~806.00 € | Tue 14 Jan 25 |
 | 2-(4,4-Difluoro-1-piperidinyl)-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine REF: 3D-FD103731CAS: 1481677-78-4 | Min. 95% | - - - | Discontinued product |
UNC-0642
CAS:1481677-78-4
Formula:
C29H44F2N6O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
546.6955
Ref: IN-DA00AQBW
| 1mg | 107.00 € | ||
| 5mg | 150.00 € | ||
| 10mg | 248.00 € | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
UNC0642
CAS:1481677-78-4
UNC0642 is an effective and specific G9a/GLP inhibitor (IC50< 2.5 nM).
Formula:
C29H44F2N6O2
Purity:
98.75% - 99.5%
Color and Shape:
Solid
Molecular weight:
546.7
Ref: TM-T4166
| 1mg | 40.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 86.00 € | ||
| 10mg | 128.00 € | ||
| 25mg | 226.00 € | ||
| 50mg | 369.00 € | ||
| 100mg | 557.00 € | ||
| 200mg | 806.00 € | ||
| 1mL*10mM (DMSO) | 94.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
![2-(4,4-Difluoro-1-piperidinyl)-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)…](https://static.cymitquimica.com/products/3D/thumb/FD103731.jpg)
2-(4,4-Difluoro-1-piperidinyl)-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine
CAS:1481677-78-4
2-(4,4-Difluoro-1-piperidinyl)-6-methoxy-N-[1-(1-methylethyl)-4-piperidinyl]-7-[3-(1-pyrrolidinyl)propoxy]-4-quinazolinamine is a retinoic acid analog that is used in the diagnosis of esophageal cancer. …
Formula:
C29H44F2N6O2
Purity:
Min. 95%
Molecular weight:
546.7 g/mol
Ref: 3D-FD103731
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information |
